{"symbol":"BMY","fiscalQuarter":"Q4-2012","reportDate":"2013-01-24","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q4-2012","postBrief":{"headline":"Bristol-Myers Squibb Beats on EPS, Stock Up 2.61%","keyNumbers":[{"metric":"EPS","actual":"$0.47","expected":"N/A","surprise":"+10.07%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based on numerical results only."},"guidanceChanges":{"summary":"No guidance data is available.","changes":[]},"whatItMeans":"Bristol-Myers Squibb reported a better-than-expected EPS for the fourth quarter of 2012, which led to a positive stock reaction, with shares rising by 2.61%. The company did not provide any revenue figures or guidance, leaving some uncertainty about future performance. Investors may view the EPS beat as a sign of underlying strength, but the lack of additional details could lead to cautious sentiment moving forward.","metaDescription":"Bristol-Myers Squibb (BMY) Q4 2012 earnings: EPS beat by 10.07%. Stock up 2.61%. Full breakdown."}}